Heat shock protein function as a target for anticancer drug discovery.

被引：0

|

作者：

Whitesell, L

Hoy, S

Marron, M

Beroza, P

机构：

[1] Telik Inc, S San Francisco, CA USA

[2] Univ Arizona, Tucson, AZ USA

来源：

CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

203

引用

收藏

页码：3693S / 3693S

页数：1

相关论文

共 50 条

[1] Heat-Shock Protein 90 (Hsp90) as Anticancer Target for Drug Discovery: An Ample Computational Perspective
Kumalo, Hezekiel M.
Bhakat, Soumendranath
Soliman, Mahmoud E.
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (05) : 1131 - 1160
[2] The molecular co-chaperone HDJ2 as a target for anticancer drug discovery.
Bagatell, R
Chen, D
Whitesell, L
CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3682S - 3683S
[3] Targeting protein ubiquitination for drug discovery. What is in the drug discovery toolbox?
Swinney, DC
DRUG DISCOVERY TODAY, 2001, 6 (05) : 244 - 250
[4] Applications of target directed fragment assembly to drug discovery.
Gordon, EM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U103 - U103
[5] Industrialization of drug discovery.
Handen, JS
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U472 - U472
[6] Pharmacophores in drug discovery.
Milne, GWA
Wang, SM
Nicklaus, MC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 47 - CINF
[7] Nr2b antagonists as a target for drug discovery.
Chenard, BL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U4 - U5
[8] Using synthetic lethality in Drosophila melanogaster for drug target discovery.
Marek, LR
Busygina, V
Bale, AE
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 237 - 237
[9] Venturing into drug discovery.
Steinmetz M.
Nature Biotechnology, 1998, 16 (Suppl 1) : 17 - 17
[10] Glycosylation in drug discovery.
Ichikawa, Y
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U262 - U262

← 1 2 3 4 5 →